What's New

Last Posted: May 12, 2023

• Utility of polygenic risk scores in UK cancer screening: a modelling analysis
  C Huntley et al, Lancet Oncology, May 2023
• Gender-specific counselling of patients with upper tract urothelial carcinoma and Lynch syndrome.
  Clara Cerrato et al. World journal of urology 2023
• Genetic determinants for the racial disparities in the risk of prostate and testicular cancers
  I Uzamere et al, Comm Med, November 2, 2022
• Prevalence of pathogenic germline cancer risk variants in testicular cancer patients: Identifying high risk groups.
  Ramamurthy Chethan et al. Urologic oncology 2022
• Familial aggregation of testicular cancer among early-onset cancer survivors. A prospective observational cohort data from Finland.
  Seikkula Heikki et al. Cancer epidemiology 2020 Oct 69101807
• Genome-wide association study of cardiovascular disease in testicular cancer patients treated with platinum-based chemotherapy.
  Steggink Lars C et al. The pharmacogenomics journal 2020 Oct
• Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors.
  Trendowski Matthew R et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Sep
• Assessment of Polygenic Architecture and Risk Prediction based on Common Variants Across Fourteen Cancers
  Y Zhan et al, BioRXIV preprint, August 9, 2019
• Lynch syndrome and urologic malignancies: a contemporary review.
  Lim Amy et al. Current opinion in urology 2019 Apr
• Testicular Cancer Biomarkers: A Role for Precision Medicine in Testicular Cancer.
  Leão Ricardo et al. Clinical genitourinary cancer 2018 Oct
• Systematic Review: An Update on the Spectrum of Urological Malignancies in Lynch Syndrome.
  Huang Dora et al. Bladder cancer (Amsterdam, Netherlands) 2018 Jul 4(3) 261-268
• Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.
  et al. JAMA oncology 2017 Feb
• Polygenic susceptibility to testicular cancer: implications for personalised health care.
  Litchfield Kevin et al. British journal of cancer 2015 Nov 113(10) 1512-8
• Cancer Risk in Relatives of Testicular Cancer Patients by Histology Type and Age at Diagnosis: A Joint Study from Five Nordic Countries.
  Kharazmi Elham et al. Eur. Urol. 2015 Aug (2) 283-9
• Nontesticular cancers in relatives of testicular germ cell tumor (TGCT) patients from multiple-case TGCT families.
  McMaster Mary L et al. Cancer Med 2015 Jul (7) 1069-78
• Prospectively Identified Incident Testicular Cancer Risk in a Familial Testicular Cancer Cohort.
  Pathak Anand et al. Cancer Epidemiol. Biomarkers Prev. 2015 Aug 11.
• Quantifying the heritability of testicular germ cell tumour using both population-based and genomic approaches.
  Litchfield Kevin et al. Sci Rep 2015 13889
• Recurrent genomic rearrangements in primary testicular lymphoma.
  Twa David D W et al. J. Pathol. 2015 Jun (2) 136-41
• Familial testicular germ cell tumors (FTGCT) - overview of a multidisciplinary etiologic study.
  Greene MH, et al. Andrology. 2014 Oct 9.
• Genetic and epigenetic analysis of monozygotic twins discordant for testicular cancer.
  Kratz CP, et al. Int J Mol Epidemiol Genet. 2014 Oct 22;5(3):135-9.

More